BOLT
Price
$0.31
Change
-$0.01 (-3.12%)
Updated
May 23, 02:07 PM (EDT)
Capitalization
12.46M
75 days until earnings call
ICCC
Price
$6.56
Change
+$0.42 (+6.84%)
Updated
May 23, 02:00 PM (EDT)
Capitalization
55.85M
76 days until earnings call
Interact to see
Advertisement

BOLT vs ICCC

Header iconBOLT vs ICCC Comparison
Open Charts BOLT vs ICCCBanner chart's image
Bolt Biotherapeutics
Price$0.31
Change-$0.01 (-3.12%)
Volume$2.9K
Capitalization12.46M
ImmuCell
Price$6.56
Change+$0.42 (+6.84%)
Volume$203
Capitalization55.85M
BOLT vs ICCC Comparison Chart
Loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. ICCC commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Hold and ICCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (BOLT: $0.32 vs. ICCC: $6.14)
Brand notoriety: BOLT and ICCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 183% vs. ICCC: 12%
Market capitalization -- BOLT: $12.46M vs. ICCC: $55.85M
BOLT [@Biotechnology] is valued at $12.46M. ICCC’s [@Biotechnology] market capitalization is $55.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileICCC’s FA Score has 0 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • ICCC’s FA Score: 0 green, 5 red.
According to our system of comparison, both BOLT and ICCC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 4 TA indicator(s) are bullish while ICCC’s TA Score has 5 bullish TA indicator(s).

  • BOLT’s TA Score: 4 bullish, 3 bearish.
  • ICCC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BOLT and ICCC are a good buy in the short-term.

Price Growth

BOLT (@Biotechnology) experienced а +2.52% price change this week, while ICCC (@Biotechnology) price change was +15.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.92%. For the same industry, the average monthly price growth was +3.01%, and the average quarterly price growth was -3.51%.

Reported Earning Dates

BOLT is expected to report earnings on Aug 06, 2025.

ICCC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+0.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICCC($55.9M) has a higher market cap than BOLT($12.5M). ICCC YTD gains are higher at: 19.223 vs. BOLT (-39.264). ICCC has higher annual earnings (EBITDA): -551.81K vs. BOLT (-70.51M). BOLT has more cash in the bank: 53.8M vs. ICCC (3.81M). ICCC has less debt than BOLT: ICCC (15.5M) vs BOLT (18.2M). ICCC has higher revenues than BOLT: ICCC (23.8M) vs BOLT (9.78M).
BOLTICCCBOLT / ICCC
Capitalization12.5M55.9M22%
EBITDA-70.51M-551.81K12,778%
Gain YTD-39.26419.223-204%
P/E RatioN/AN/A-
Revenue9.78M23.8M41%
Total Cash53.8M3.81M1,412%
Total Debt18.2M15.5M117%
FUNDAMENTALS RATINGS
ICCC: Fundamental Ratings
ICCC
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTICCC
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 10 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.60N/A
N/A
Cue Biopharma
CVRX6.26N/A
N/A
CVRx
SHW353.94N/A
N/A
Sherwin-Williams Company (The)
HWKN126.67-0.34
-0.27%
Hawkins
POST107.94-0.90
-0.83%
Post Holdings

ICCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCC has been loosely correlated with NKTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ICCC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCC
1D Price
Change %
ICCC100%
N/A
NKTX - ICCC
43%
Loosely correlated
N/A
ATHE - ICCC
27%
Poorly correlated
N/A
BOLT - ICCC
26%
Poorly correlated
+2.52%
TRAW - ICCC
24%
Poorly correlated
+5.00%
XENE - ICCC
24%
Poorly correlated
+0.10%
More